Poland· PL-100463119

Heparinum WZF

A heparin product containing heparinum natricum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC B01AB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedHeparinum WZFATCB01AB01REGISTER NO.PL-100463119PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Heparin is registered in 12 of 19 countries.

Countries holding a registration under ATC B01AB01 (heparin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Heparin · ATC B01AB01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Heparinum natricum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
B01AB01
ATC class
Heparin
Defined daily dose
10 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991473983

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

714 interactions on record for heparin.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Heparin · interactions on record

714 records

  • 63 severe
  • 133 moderate
  • 18 minor
  • 500 info

Most severe, free to view

  • InotersenN07XX15severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Heparin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All heparin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Depot-Heparin Gilvasan, Heparin Gilvasan
  • Belgium · Heparine Leo, Heparine Natrium B. Braun
  • Bulgaria · Heparin Glk, Виатромб
  • Cyprus · Heparin Gilvasan, Heparin Sodium Pinewood Laboratories
  • Czechia · Heparin Léčiva, Lioton
  • Germany · Axicur, Hepa Lichtenstein
  • Denmark · Heparin "leo", Heparin Leo
  • Estonia · Heparin Sodium Auxilia, Lioton
  • Spain · Heparin Sodium Sala, Heparina Sódica Rovi
  • Finland · Heparin Leo
  • France · Heparine Choay, Heparine Leo
  • United Kingdom (Northern Ireland) · Canusal, Heparin (Mucous) Leo Laboratories
  • Greece · Heparin/Leo
  • Croatia · Heparin Belupo, Heparin Panpharma
  • Hungary · Heparin Galenika, Lioton
  • Ireland · Heparin Sodium Pinewood Laboratories
  • Iceland · Heparin Leo
  • Italy · Eparina Vister, Epsoclar
  • Lithuania · Heparin Sodium Panpharma, Lioton
  • Luxembourg · Heparin Ratiopharm, Heparin-Natrium Braun
  • Latvia · Heparīna Nātrijs Panpharma, Lioton
  • Malta · Heparin Sodium Sala, Heparin Sodium Wockhardt Uk
  • Netherlands · Heparine Leo
  • Norway · Heparin Panpharma
  • Portugal · Heparina Leo, Heparina Panpharma
  • Romania · Heparin, Heparină Sodică Panpharma
  • Sweden · Heparin Leo
  • Slovenia · Heparin Braun, Lioton
  • Slovakia · Heparin Al, Heparin Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/97995b01-008d-4da1-8c8f-cd1c5fc19fad
GET /v1/drugs/97995b01-008d-4da1-8c8f-cd1c5fc19fad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "5000 IU/ml",
  "packaging": "05909991473983 ¦ Rp ¦ 143244\n10 fiol. 5 ml",
  "substance": "Heparinum natricum 5000 IU/ml",
  "common_name": "Heparinum natricum",
  "pl_product_id": "100463119",
  "pozwolenie_nr": "14/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-01-11"
}

See everything about heparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.